RAFAEL HOLDINGS, INC. Payments to Acquire Investments
RAFAEL HOLDINGS, INC. (RFL) reported Payments to Acquire Investments of $25.00 million for the 6-month period ending 2022-01-31, per its 10-Q filed 2023-03-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2023-03-14
- RAFAEL HOLDINGS, INC. payments to acquire investments for the quarter ending 2022-01-31 was $0.00.
- RAFAEL HOLDINGS, INC. payments to acquire investments for the quarter ending 2021-10-31 was $25.00M.
- RAFAEL HOLDINGS, INC. payments to acquire investments for the quarter ending 2021-07-31 was $0.00.
- RAFAEL HOLDINGS, INC. payments to acquire investments for the quarter ending 2021-04-30 was $0.00.
- RAFAEL HOLDINGS, INC. payments to acquire investments for fiscal 2021 was $9.12M.
- RAFAEL HOLDINGS, INC. payments to acquire investments for fiscal 2019 was $55.87M, a 36900.00% increase from fiscal 2018.
- RAFAEL HOLDINGS, INC. payments to acquire investments for fiscal 2018 was $151.00K, a 98.39% decline from fiscal 2017.
- RAFAEL HOLDINGS, INC. payments to acquire investments for fiscal 2017 was $9.40M, a 347.62% increase from fiscal 2016.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 3 month as first filed | Payments to Acquire Investments 6 month | Payments to Acquire Investments 6 month as first filed | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|---|---|
| 2022-01-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14 | $25.00M 10-Q · filed 2023-03-14 | $25.00M derived: sum of 3 quarters · filed 2023-03-14 | $25.00M derived: sum of 4 quarters · filed 2023-03-14 | ||
| 2021-10-31 | $25.00M 10-Q · filed 2022-12-13 | $25.00M derived: sum of 2 quarters · filed 2022-12-13 | $25.00M derived: sum of 3 quarters · filed 2022-12-13 | |||
| 2021-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $0.00 derived: sum of 2 quarters · filed 2022-10-31 | $9.12M 10-K · filed 2022-10-31 | |||
| 2021-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-06-14 | $9.12M 10-Q · filed 2022-06-14 | ||||
| 2021-01-31 | $9.12M 10-Q · filed 2022-03-17 | $1.00M 10-Q · filed 2021-03-17 | ||||
| 2019-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-29 | $0.00 derived: sum of 2 quarters · filed 2020-10-29 | $45.87M derived: sum of 3 quarters · filed 2020-10-29 | $55.87M 10-K · filed 2020-10-29 | ||
| 2019-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-09 | $45.87M derived: sum of 2 quarters · filed 2020-06-09 | $55.87M 10-Q · filed 2020-06-09 | |||
| 2019-01-31 | $45.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-03-05 | $55.87M 10-Q · filed 2020-03-05 | ||||
| 2018-10-31 | $10.00M 10-Q · filed 2019-12-09 | $953.00K 10-Q · filed 2018-12-10 | ||||
| 2018-07-31 | $151.00K 10-K · filed 2019-10-04 | |||||
| 2017-07-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-15 | $1.10M derived: sum of 2 quarters · filed 2018-10-15 | $9.40M 10-K · filed 2018-10-15 | |||
| 2017-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-06-11 | $8.30M 10-Q · filed 2018-06-11 | ||||
| 2017-01-31 | $8.30M 10-Q · filed 2018-03-12 | |||||
| 2016-07-31 | $2.10M 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |